Clinical Trial Update: Safety and Behavior of S. Aureus Immune Globulin Intravenous(Human), [Altastaph] in Patients With S. Aureus Bacteremia and Continuing Fever [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical trials evaluated the safety and behavior of Altastaph (Staphylococcus aureus immune globulin intravenous) in patients with Staphylococc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcus Aureus Bacteremia
• Staphylococcus Aureus Infection

Drugs mentioned

• Altastaph (Staphylococcus aureus immune globulin intravenous (Human))

Snippet

Sponsor: Nabi Biopharmaceuticals | Conditions: Staphylococcal Infections | Phase 1, Phase 2 | Status: COMPLETED